Families who have saved their children’s cord blood with Cord Blood Registry® now have access to a new use for the stem cells. A new clinical trial will investigate using a child’s own cord blood stem cells as treatment after a pediatric stroke. Below are details on how Cord Blood Registry is helping uncover new potential uses for cord blood stem cells.
Watch Video: A little boy impaired by stroke exceeds expectations.
How does this study work?
The trial will enroll 10 children who have their umbilical cord blood banked with Cord Blood Registry, have experienced a perinatal stroke and who meet the inclusion criteria for the study. Children up to 6 years of age who suffered a perinatal stroke and who have access to their own CBR-processed cord blood cells may be eligible for the study. Please contact us if your child meets these criteria and is suffering from the effects of a stroke.